| Literature DB >> 29062822 |
Rodrigo Amaral1, Ronaldo Ferreira1, Luis Marchi1, Rubens Jensen1, Joes Nogueira-Neto1, Luiz Pimenta1,2.
Abstract
OBJECTIVES: Historically, anterior lumbar interbody fusion (ALIF) was related to high rates of intraoperative complications and adverse events related to interbody devices. In recent decades, there have been technical adjustments, and cages that are more suitable have emerged. The aim of this study is to evaluate the efficacy and complication rate of the use of stand-alone mini-ALIF using a self-locking cage.Entities:
Keywords: Arthrodesis; Lumbar vertebrae; Spinal fusion; Spine
Year: 2017 PMID: 29062822 PMCID: PMC5643906 DOI: 10.1016/j.rboe.2017.08.016
Source DB: PubMed Journal: Rev Bras Ortop ISSN: 2255-4971
Fig. 1Images representing anterior retroperitoneal access to the L5-S1 disc space. (A) Abdominal incision; (B) passage through the abdominal muscles; (C) identification of the bifurcation of the great vessels in front of the disc space of L5S1; (D) exposure of the anterior face of the intervertebral disc; (E) discectomy and preparation of the disc space for arthrodesis and (F) interbody implant secured with locking screws into the disc space.
Fig. 2Images of intraoperative fluoroscopy showing final positioning of the interbody spacer. (A) Lateral view and (B) anteroposterior view evidencing the titanium spacer and the locking screws towards the adjacent vertebral bodies.
Demographic and preoperative data.
| Total ( | 87 |
| Age (years) | 44 ± 11 |
| Gender (female) | 50 (64%) |
| BMI (kg/m2) | 26.6 ± 4.1 |
| Levels treated | 87 |
| Disc degenerative disease | 45 (51%) |
| DDD + stenosis | 19 (22%) |
| Spondylolisthesis | 16 (18%) |
| Post discectomy | 8 (9%) |
| L5S1 | 81 (93%) |
| L4TV | 2 (2%) |
| L5TV | 4 (4%) |
BMI, body mass index; DDD, disc degenerative disease.
Values shown in median ± standard deviation or in absolute number (and percentage).
Surgical and perioperative data.
| Duration | 90 (98) ± 24 min |
| Blood loss | 100 (171) ± 455 mL |
| ICU admission | 0 (0.2) ± 0.2 dia |
| Hospital admission | 1.5 (1.6) ± 0.6 dia |
Values shown in median (mean) ± standard deviation.
Adverse events.
| | ||
| Venous damage (1 | 2 (1 | 2% |
| Arterial damage | 0 | 0% |
| | 2 | 2% |
| | 0 | 0% |
| | ||
| Superficial | 1 | 1% |
| Deep | 0 | 0% |
| | 1 | 1% |
| | 1 | 1% |
| | 1 | 1% |
| | 0 | 0% |
| | 2 | 2% |
| | 4 | 5% |
| | 7 | 8% |
Values shown in absolute numbers and percentage.
Major adverse events.
Short-term clinical results.
| Preop | 1 week | 6 weeks | 3 months | |
|---|---|---|---|---|
| Back VAS | 7.4 | 4.0 | 3.7 | 4.2 |
| Lower limbs VAS | 5.1 | 3 | 2.9 | 2.8 |
| ODI | 44 | 39 | 34 | 31 |
| EQ-5D | 0.59 | 0.65 | 0.70 | 0.76 |
Values shown in mean.
Statistically lower than the preoperative value.